Regeneron Pharmaceuticals, Inc. vs The Sherwin-Williams Company
Comparaison de la capitalisation boursière au fil du temps
Regeneron Pharmaceuticals, Inc.
$81.4B
Rang #194
The Sherwin-Williams Company
$81.8B
Rang #190
Capitalisation boursière au fil du temps
Moments clés
- Regeneron Pharmaceuticals, Inc. a dépassé The Sherwin-Williams Company avant 1995
- The Sherwin-Williams Company a dépassé Regeneron Pharmaceuticals, Inc. avant 1997
- Regeneron Pharmaceuticals, Inc. a dépassé The Sherwin-Williams Company avant 1999
- The Sherwin-Williams Company a dépassé Regeneron Pharmaceuticals, Inc. avant 2003
- Regeneron Pharmaceuticals, Inc. a dépassé The Sherwin-Williams Company avant 2012
- The Sherwin-Williams Company a dépassé Regeneron Pharmaceuticals, Inc. avant 2019
- Regeneron Pharmaceuticals, Inc. a dépassé The Sherwin-Williams Company avant 2022
- The Sherwin-Williams Company a dépassé Regeneron Pharmaceuticals, Inc. avant 2024
Comparaison année par année
| Année | Regeneron Pharmaceuticals, Inc. | The Sherwin-Williams Company | Leader |
|---|---|---|---|
| 2026 | $81.4B | $81.8B | The Sherwin-Williams Company |
| 2025 | $79.3B | $79.5B | The Sherwin-Williams Company |
| 2024 | $72.8B | $82.7B | The Sherwin-Williams Company |
| 2023 | $89.7B | $75.3B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.7B | $56.7B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $64.5B | $83.3B | The Sherwin-Williams Company |
| 2020 | $49.4B | $57.5B | The Sherwin-Williams Company |
| 2019 | $38.4B | $45.3B | The Sherwin-Williams Company |
| 2018 | $38.2B | $30.2B | Regeneron Pharmaceuticals, Inc. |
| 2017 | $38.4B | $31.2B | Regeneron Pharmaceuticals, Inc. |
| 2016 | $37.5B | $20.3B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $55.5B | $19.3B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $41.9B | $19.4B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $28.1B | $13.4B | Regeneron Pharmaceuticals, Inc. |
| 2012 | $17.5B | $11.1B | Regeneron Pharmaceuticals, Inc. |
| 2011 | $5.7B | $6.4B | The Sherwin-Williams Company |
| 2010 | $3.4B | $5.9B | The Sherwin-Williams Company |
| 2009 | $2.5B | $4.2B | The Sherwin-Williams Company |
| 2008 | $1.9B | $4.0B | The Sherwin-Williams Company |
| 2007 | $2.5B | $3.8B | The Sherwin-Williams Company |
| 2006 | $2.1B | $4.1B | The Sherwin-Williams Company |
| 2005 | $1.6B | $2.9B | The Sherwin-Williams Company |
| 2004 | $941.1M | $2.7B | The Sherwin-Williams Company |
| 2003 | $1.5B | $2.1B | The Sherwin-Williams Company |
| 2002 | $1.9B | $1.7B | Regeneron Pharmaceuticals, Inc. |
| 2001 | $2.9B | $1.6B | Regeneron Pharmaceuticals, Inc. |
| 2000 | $3.6B | $1.5B | Regeneron Pharmaceuticals, Inc. |
| 1999 | $1.3B | $1.2B | Regeneron Pharmaceuticals, Inc. |
| 1998 | $753.6M | $1.6B | The Sherwin-Williams Company |
| 1997 | $874.9M | $1.5B | The Sherwin-Williams Company |
| 1996 | $1.6B | $1.5B | Regeneron Pharmaceuticals, Inc. |
| 1995 | $1.3B | $1.1B | Regeneron Pharmaceuticals, Inc. |
| 1994 | $306.5M | $850.4M | The Sherwin-Williams Company |